This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y.-H. Articles by Noteborn, M. H. M. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y.-H. Articles by Noteborn, M. H. M.

Activation of the Tumor-Specific Death Effector Apoptin and Its Kinase by an N-Terminal Determinant of Simian Virus 40 Large T Antigen

Leadd B.V.,¹ BFSC, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands²

Received 11 December 2003/ Accepted 5 May 2004

Apoptin, a viral death protein derived from chicken anemia virus, displays a number of tumor-specific behaviors. In particular, apoptin is phosphorylated, translocates to the nucleus, and induces apoptosis specifically in tumor or transformed cells, whereas it is nonphosphorylated and remains primarily inactive in the cytoplasm of nontransformed normal cells. Here, we show that in normal cells apoptin can also be activated by the transient transforming signals conferred by ectopically expressed simian virus 40 (SV40) large T antigen (LT), which rapidly induces apoptin's phosphorylation, nuclear accumulation, and the ability to induce apoptosis. Further analyses with mutants of LT showed that the minimum domain capable of inducing all three of apoptin's tumor-specific properties resided in the N-terminal J domain, a sequence which is largely shared by SV40 small t antigen (st). Interestingly, the J domain in st, which lacks its own nuclear localization signal (NLS), required nuclear localization to activate apoptin. These results reveal the existence of a cellular pathway shared by conditions of transient transformation and the stable cancerous or precancerous state, and they support a model whereby a transient transforming signal confers on apoptin both the upstream activity of phosphorylation and the downstream activity of nuclear accumulation and apoptosis induction. Such a pathway may reflect a general lesion contributing to human cancers.

This article has been cited by other articles:

• Maddika, S., Booy, E. P., Johar, D., Gibson, S. B., Ghavami, S., Los, M. (2005). Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J. Cell Sci. 118: 4485-4493 [Abstract] [Full Text]  
• Rohn, J. L., Zhang, Y.-H., Leliveld, S. R., Danen-van Oorschot, A. A. A. M., Henriquez, N. V., Abrahams, J. P., Noteborn, M. H. M. (2005). Relevance of Apoptin's Integrity for Its Functional Behavior. J. Virol. 79: 1337-1338 [Full Text]